FeedTheBull | Stock Market News

Three Missed Opportunities

buylikebuffett — Fri, 09 Jan 2009 17:13:07 -0500

Below is a list of some investments that I wish i had pulled the trigger on:

A Tale of Two Retailers

buylikebuffett — Fri, 09 Jan 2009 16:54:31 -0500

Walmart was not immune to the economic downturn as so many analysts had predicted. Walmart saw its same store sales increase by 1.7% last month. Good news

Intra Day Market Technical Analysis Video 01-09-09

inthemoneystocks — Fri, 09 Jan 2009 15:50:54 -0500

A Stock Canidate That Walter Schloss Might Like!

stockmanmarc — Fri, 09 Jan 2009 15:48:44 -0500

The market will always offer up some undervalued certain securities, but the best time to look for them is when there's panic and fear on Wall Street, Schloss often said. Buffett often quotes the same. Great minds think alike.

Graham + Greenblatt = The GG Formula

stockmanmarc — Fri, 09 Jan 2009 15:31:18 -0500

Here are a few stocks that meet some of the characteristics that Ben Graham and Joel Greenblatt might consider...

Eddie Lampert Pulls A Coup d'etat Over Other Retailers!

stockmanmarc — Fri, 09 Jan 2009 15:12:52 -0500

It looks like Eddie and his
Sears Holding(SHLD) company are showing some adversity...

Gold Fundamentals Remain Awesomely Bullish

norman rockefeller — Fri, 09 Jan 2009 14:25:20 -0500

During late 2008's unprecedented financial-market panic, gold got something of a bum rap. Since this metal didn't soar during the stock chaos like most of its investors expected, many assume something must be wrong in gold-land. But gold ultimately did hold its own, up 2.1% in Q4 while the S&P 500 plunged 22.4%.

During the very heart of the stock panic...

Market Trend Remains Intact

Kingsley — Fri, 09 Jan 2009 14:06:08 -0500

Article discusses the fact that while the current up trend is weak, it still remains intact for the reasons herein.

More Good News From the Commodity Front

norman rockefeller — Fri, 09 Jan 2009 14:02:00 -0500

This week, we've looked across the New Year's divide to recapitulate and prognosticate (with a little hip-hop back beat, that title could become a rap classic, no?). After looking at exchange-traded products (ETPs) tracking gold on Wednesday ("2008 Was Golden ... Barely"), Thursday's focus ("A Real Commodity Moneymaker") was the ELEMENTS S&P CTI ETN (NYSE: LSC).

"Wars and Rumors of Wars" = Time to Look at Defense Stocks?

MissMktr — Fri, 09 Jan 2009 13:51:16 -0500

With war on the horizon, Justice Litle thinks it is about time to start investing in defense stocks.

Endologix, Inc. (ELGX) Anticipates Reporting Significant Revenue Growth for 2008; Issues 2009 Guidance

QualityStocks.net — Fri, 09 Jan 2009 12:51:53 -0500

Endologix, Inc. announced that it is expecting the revenue generated during last year to total approximately $37.6 million, a 35% increase from 2007 revenue of $27.8 million. The company anticipates reporting Q4 2008 revenue of approximately $10.7 million, up 35% from total product revenue of $7.9 million reported for Q4 2007.

Cosi, Inc. (COSI) is “One to Watch”

QualityStocks.net — Fri, 09 Jan 2009 12:50:26 -0500

Cosi, Inc. is a national premium convenience restaurant chain that offers a menu built around a secret, generations-old recipe for crackly crust flatbread. This artisan bread is freshly baked in front of customers all day long in open flame stone hearth ovens. The warm, urbane atmosphere is designed to attract its sophisticated, upscale, urban and suburban guests.

ICO Global Communications Ltd. (ICOG) Completes Testing of ICO G1 Space Segment

QualityStocks.net — Fri, 09 Jan 2009 12:49:24 -0500

ICO Global Communications Ltd. announced that the testing of ICO G1 satellite In Orbit (IOT) and the innovative Ground Based Beam Forming (GBBF) system for the ICO Space Segment is now complete. In the press release, the company also announced its subsidiary, ICO Satellite Services G.P., has accepted the Space Segment from Space Systems/Loral.

Anadys Pharmaceuticals, Inc. (ANDS) Stock Rises More Than 90% After Release of Clinical Trial Results

QualityStocks.net — Fri, 09 Jan 2009 12:48:23 -0500

Anadys Pharmaceuticals, Inc. announced positive results from the first cohort of an ongoing Phase Ib clinical trial of ANA598, the Company’s investigational non-nucleoside polymerase inhibitor. ANA598 demonstrated potent antiviral activity in patients infected with chronic Hepatitis C virus (HCV) and was very well-tolerated. The company anticipates reporting detailed data from multiple cohorts of the study at an upcoming medical conference.

Anesiva, Inc. (ANSV) Receives FDA Approval for Supplemental New Drug Application to Expand Zingo(TM) Indication

QualityStocks.net — Fri, 09 Jan 2009 12:47:13 -0500

Anesiva, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) to expand the indication for Zingo(TM) to treat adults’ pain associated with blood draws. Previously, Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system was only approved to treat the pain caused by peripheral IV insertions and blood draws in children aging 3-18 years.